These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34612013)

  • 1. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas.
    Ye L; Xu Y; Wang L; Zhang C; Hu P; Tong S; Liu Z; Tian D
    Cancer Med; 2021 Nov; 10(22):8100-8113. PubMed ID: 34612013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
    Mou Y; Zhang L; Liu Z; Song X
    BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
    Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
    Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses.
    Yang Z; Gong W; Zhang T; Gao H
    Front Oncol; 2021; 11():729137. PubMed ID: 34660294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
    Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
    Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
    Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN
    Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic biomarker HIF1α and its correlation with immune infiltration in gliomas.
    Ding Z; Zhang J; Li L; Wang C; Mei J
    Oncol Lett; 2024 May; 27(5):193. PubMed ID: 38495835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
    Yang G; Tang S; Zhang J; Qin L
    World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
    Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
    Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas.
    Wang P; Zhang J; He S; Xiao B; Peng X
    Cancer Cell Int; 2020 Nov; 20(1):573. PubMed ID: 33292262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis.
    Ma K; Chen X; Zhao X; Chen S; Yang J
    Heliyon; 2022 Aug; 8(8):e10298. PubMed ID: 36033326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.